Left-to-right cardiac shunt: perioperative anesthetic considerations

Alan D Kaye1, Tyler B Stout, Ira W Padnos

  • 1Department of Anesthesiology, Louisiana State University Health Sciences Center, Louisiana State University School of Medicine, 1542 Tulane Ave, Room 656, New Orleans, LA 70112, USA. akaye@lsuhsc.edu

Insights

Congenital heart disease (CHD) with left-to-right shunts impacts more adults due to medical advances. Anesthetic management for these patients requires understanding unique cardiopulmonary changes and pharmacodynamics for safe surgical care.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Pediatric Surgery

Background:

  • Congenital heart disease (CHD) affects 8/1000 live births, with improved survival into adulthood for those with left-to-right shunts.
  • Surgical care for these patients necessitates a deep understanding of altered cardiopulmonary physiology and treatment strategies.
  • Common left-to-right shunts include atrial septal defect (ASD), ventricular septal defect (VSD), endocardial cushion defect (ECD), and patent ductus arteriosus (PDA).

Purpose of the Study:

  • To review current concepts and general principles of perioperative anesthetic management for congenital heart disease (CHD) patients.
  • To discuss specific anesthetic techniques and the pharmacodynamic/pharmacokinetic effects of agents in patients with left-to-right shunts.
  • To highlight the importance of specialized anesthetic care for adults with CHD undergoing surgery.

Main Methods:

  • Review of current literature on anesthetic management in congenital heart disease.
  • Analysis of physiological changes associated with left-to-right shunts, including pulmonary vascular resistance (PVR) and pulmonary arterial hypertension (PAH).
  • Examination of anesthetic agents' effects in the context of altered hemodynamics and pharmacokinetics in CHD patients.

Main Results:

  • Increased pulmonary vascular resistance (PVR) and pulmonary arterial hypertension (PAH) are key pathological changes in left-to-right shunts.
  • These changes can lead to Eisenmenger Syndrome and heart failure if uncorrected.
  • Early surgical or trans-catheter repair is generally indicated for these cardiac defects.

Conclusions:

  • Perioperative anesthetic management for adults with CHD requires specialized knowledge of cardiopulmonary alterations.
  • Understanding the unique effects of anesthetic agents is crucial for optimizing patient outcomes.
  • Neuraxial anesthesia and other advanced techniques should be considered within the context of the patient's specific cardiac defect and physiology.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.